Biomega Unveils Whitepaper on Role of Salmon Peptides in Supporting Cardiovascular Health
Biomega Group released a new whitepaper discussing how bioactive salmon peptides could help to manage weight and minimise the risk factors associated with human and pet obesity.
“Salmon Peptides and their potential role in weight management” is the second in a series of releases from Biomega explaining the scientific advantages that salmon bioactive peptides could have on human and animal well being. The whitepaper, which follows the company’s first document on cardiovascular health, is available to download for free.
“With global obesity levels in humans and animals rising year-on-year, there is a growing demand for functional food ingredients that have demonstrated their efficacy to help manage weight through safe, secure and science-backed studies,” said Bjørn Liaset, director of R&D at Biomega. “Our whitepaper explores how salmon protein hydrolysates can help to manage weight and combat health conditions relating to obesity in humans and animals. Considering substantial scientific evidence and reference to several published studies, the document outlines how bioactive salmon peptides can theoretically reduce inflammation in visceral adipose tissue and significantly decrease body mass index.”